<VariationArchive VariationID="10967" VariationName="NM_000475.5(NR0B1):c.1231_1234del (p.Leu411fs)" VariationType="Deletion" Accession="VCV000010967" Version="5" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-28" DateCreated="2013-04-04" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26006" VariationID="10967">
      <GeneList>
        <Gene Symbol="NR0B1" FullName="nuclear receptor subfamily 0 group B member 1" GeneID="190" HGNC_ID="HGNC:7960" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="30304206" stop="30309390" display_start="30304206" display_stop="30309390" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="30322538" stop="30327494" display_start="30322538" display_stop="30327494" Strand="-" />
          </Location>
          <OMIM>300473</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR0B1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-05" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NR0B1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000475.5(NR0B1):c.1231_1234del (p.Leu411fs)</Name>
      <CanonicalSPDI>NC_000023.11:30304757:TGAGT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="30304758" stop="30304761" display_start="30304758" display_stop="30304761" variantLength="4" positionVCF="30304757" referenceAlleleVCF="CTGAG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="30322875" stop="30322878" display_start="30322875" display_stop="30322878" variantLength="4" positionVCF="30322874" referenceAlleleVCF="CTGAG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>L411fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_858" sequenceAccession="LRG_858">
            <Expression>LRG_858:g.9618_9621del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_858t1" sequenceAccession="LRG_858t1">
            <Expression>LRG_858t1:c.1231_1234del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_858p1" sequenceAccession="LRG_858p1" change="p.Leu411fs">
            <Expression>LRG_858p1:p.Leu411fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000475.5" sequenceAccession="NM_000475" sequenceVersion="5" change="c.1231_1234delCTCA" MANESelect="true">
            <Expression>NM_000475.5:c.1231_1234delCTCA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.30322876_30322879del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.30322876_30322879del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.30304759_30304762del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.30304759_30304762del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009814.1" sequenceAccession="NG_009814" sequenceVersion="1" change="g.9618_9621del">
            <Expression>NG_009814.1:g.9618_9621del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000475.5" sequenceAccession="NM_000475" sequenceVersion="5" change="c.1231_1234del" MANESelect="true">
            <Expression>NM_000475.5:c.1231_1234del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000466.2" sequenceAccession="NP_000466" sequenceVersion="2" change="p.Leu411fs">
            <Expression>NP_000466.2:p.Leu411fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300473.0019" DB="OMIM" />
        <XRef Type="rs" ID="1569268070" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000475.5(NR0B1):c.1231_1234del (p.Leu411fs) AND Congenital adrenal hypoplasia, X-linked" Accession="RCV000011714" Version="3">
        <ClassifiedConditionList TraitSetID="3046">
          <ClassifiedCondition DB="MedGen" ID="C0342482">Congenital adrenal hypoplasia, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-05-18" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000475.5(NR0B1):c.1231_1234del (p.Leu411fs) AND multiple conditions" Accession="RCV002512973" Version="2">
        <ClassifiedConditionList TraitSetID="10091">
          <ClassifiedCondition DB="MedGen" ID="C1848296">46,XY sex reversal 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0342482">Congenital adrenal hypoplasia, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-17" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-17" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2013-04-04" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10361383</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34193132</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="10091" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="87" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal hypoplasia, X-linked</ElementValue>
                <XRef ID="Congenital+adrenal+hypoplasia%2C+X-linked/7542" DB="Genetic Alliance" />
                <XRef ID="237764004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Isolated X-Linked Adrenal Hypoplasia Congenita</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENAL HYPOPLASIA, CONGENITAL, WITH HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked AHC</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adrenal hypoplasia, congenital</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">X-AHC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AHC</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AHCH</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">NR0B1-related adrenal hypoplasia congenita includes both X-linked adrenal hypoplasia congenita (X-linked AHC) and Xp21 deletion (previously called complex glycerol kinase deficiency). X-linked AHC is characterized by primary adrenal insufficiency and/or hypogonadotropic hypogonadism (HH). Adrenal insufficiency is acute infantile onset (average age 3 weeks) in approximately 60% of affected males and childhood onset (ages 1-9 years) in approximately 40%. HH typically manifests in a male with adrenal insufficiency as delayed puberty (i.e., onset age &gt;14 years) and less commonly as arrested puberty at about Tanner Stage 3. Rarely, X-linked AHC manifests initially in early adulthood as delayed-onset adrenal insufficiency, partial HH, and/or infertility. Heterozygous females very occasionally have manifestations of adrenal insufficiency or hypogonadotropic hypogonadism. Xp21 deletion includes deletion of NR0B1 (causing X-linked AHC) and GK (causing glycerol kinase deficiency), and in some cases deletion of DMD (causing Duchenne muscular dystrophy). Developmental delay has been reported in males with Xp21 deletion when the deletion extends proximally to include DMD or when larger deletions extend distally to include IL1RAPL1 and DMD.</Attribute>
                <XRef ID="NBK1431" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="555" />
                <XRef ID="555" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301604</ID>
                <ID Source="BookShelf">NBK1431</ID>
              </Citation>
              <XRef ID="95702" DB="Orphanet" />
              <XRef ID="C0342482" DB="MedGen" />
              <XRef ID="MONDO:0010264" DB="MONDO" />
              <XRef Type="MIM" ID="300200" DB="OMIM" />
            </Trait>
            <Trait ID="1986" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">46XY sex reversal 2, dosage-sensitive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dosage-sensitive sex reversal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NR0B1-Related 46,XY CGD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NR0B1-related 46,XY complete gonadal dysgenesis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">46,XY SEX REVERSAL, DAX1-RELATED</ElementValue>
                <XRef Type="MIM" ID="300018" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">46,XY sex reversal 2</ElementValue>
                <XRef ID="MONDO:0010226" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SRXY2</ElementValue>
                <XRef Type="MIM" ID="300018" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DSS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9159" />
                <XRef ID="9159" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="LWPES/ESPE, 2006">
                <ID Source="PubMed">18947601</ID>
              </Citation>
              <XRef ID="C1848296" DB="MedGen" />
              <XRef ID="MONDO:0010226" DB="MONDO" />
              <XRef Type="MIM" ID="300018" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3046" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="87" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital adrenal hypoplasia, X-linked</ElementValue>
                <XRef ID="Congenital+adrenal+hypoplasia%2C+X-linked/7542" DB="Genetic Alliance" />
                <XRef ID="237764004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Isolated X-Linked Adrenal Hypoplasia Congenita</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENAL HYPOPLASIA, CONGENITAL, WITH HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked AHC</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adrenal hypoplasia, congenital</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">X-AHC</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AHC</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AHCH</ElementValue>
                <XRef Type="MIM" ID="300200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">NR0B1-related adrenal hypoplasia congenita includes both X-linked adrenal hypoplasia congenita (X-linked AHC) and Xp21 deletion (previously called complex glycerol kinase deficiency). X-linked AHC is characterized by primary adrenal insufficiency and/or hypogonadotropic hypogonadism (HH). Adrenal insufficiency is acute infantile onset (average age 3 weeks) in approximately 60% of affected males and childhood onset (ages 1-9 years) in approximately 40%. HH typically manifests in a male with adrenal insufficiency as delayed puberty (i.e., onset age &gt;14 years) and less commonly as arrested puberty at about Tanner Stage 3. Rarely, X-linked AHC manifests initially in early adulthood as delayed-onset adrenal insufficiency, partial HH, and/or infertility. Heterozygous females very occasionally have manifestations of adrenal insufficiency or hypogonadotropic hypogonadism. Xp21 deletion includes deletion of NR0B1 (causing X-linked AHC) and GK (causing glycerol kinase deficiency), and in some cases deletion of DMD (causing Duchenne muscular dystrophy). Developmental delay has been reported in males with Xp21 deletion when the deletion extends proximally to include DMD or when larger deletions extend distally to include IL1RAPL1 and DMD.</Attribute>
                <XRef ID="NBK1431" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="555" />
                <XRef ID="555" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000520059" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301604</ID>
                <ID Source="BookShelf">NBK1431</ID>
              </Citation>
              <XRef ID="95702" DB="Orphanet" />
              <XRef ID="C0342482" DB="MedGen" />
              <XRef ID="MONDO:0010264" DB="MONDO" />
              <XRef Type="MIM" ID="300200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31946" SubmissionDate="2012-09-18" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300473.0019_ADRENAL HYPOPLASIA, CONGENITAL" title="NR0B1, 4-BP DEL, NT1464_ADRENAL HYPOPLASIA, CONGENITAL" />
        <ClinVarAccession Accession="SCV000031946" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 42-year-old patient who had congenital adrenal hypoplasia with hypogonadotropic hypogonadism (300200), Wang et al. (1999) identified a 4-bp deletion (1464delACTC) in the second exon of the NR0B1 sequence, which caused a frameshift and predicted a premature stop codon at amino acid 416. The diagnosis of AHC and HHG had been made at 2 weeks of age when he presented to the Hospital for Sick Children in Toronto with vomiting, loose stools, and failure to thrive. He was treated with intramuscular deoxycortisone acetate (DOCA) and discharged with 2 subcutaneous DOCA pellets. Prednisone was started with added salt at the age of 23 months. He had been maintained on glucocorticoids since that time. At age 15 he developed a slipped left femoral epiphysis, which was treated surgically. His bone age at that time was 11 years. He had no secondary sexual development when studied at the age of 17 years and was started on testosterone. No other family members were affected.</Attribute>
              <Citation>
                <ID Source="PubMed">10361383</ID>
              </Citation>
              <XRef DB="OMIM" ID="300200" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR0B1" />
          </GeneList>
          <Name>NR0B1, 4-BP DEL, NT1464</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, NT1464</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300473.0019" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ADRENAL HYPOPLASIA, CONGENITAL</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3255188" SubmissionDate="2021-05-24" DateLastUpdated="2021-06-03" DateCreated="2021-06-03">
        <ClinVarSubmissionID localKey="SUB9725861" submittedAssembly="GRCh37" title="SUB9725861" />
        <ClinVarAccession Accession="SCV001652695" DateUpdated="2021-06-03" DateCreated="2021-06-03" Type="SCV" Version="1" SubmitterName="Department of Pediatric Endocrinology and Inherited Metabolic Diseases, Children's Hospital of Fudan University" OrgID="508091" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-18">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ADRENAL HYPOPLASIA, CONGENITAL with tiny adrenal glands and mineralocorticoid deficiency</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Asian</Ethnicity>
              <GeographicOrigin>China</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000835" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0004319" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR0B1">
              <Name>nuclear receptor subfamily 0 group B member 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000475.5:c.1231_1234delCTCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300200" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9725861</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6133367" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4966965|MedGen:C0342482;C1848296" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003444667" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10361383</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34193132</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu411Valfs*6) in the NR0B1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 60 amino acid(s) of the NR0B1 protein. This premature translational stop signal has been observed in individual(s) with primary adrenal insufficiency and/or X-linked adrenal hypoplasia (PMID: 10361383, 34193132). In at least one individual the variant was observed to be de novo. This variant is also known as 1464 delACTC. ClinVar contains an entry for this variant (Variation ID: 10967). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NR0B1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.30322875_30322878del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342482" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1848296" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3255188" TraitType="Finding" MappingType="XRef" MappingValue="HP:0004319" MappingRef="HP">
        <MedGen CUI="C0857899" Name="Decreased circulating aldosterone level" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="31946" TraitType="Disease" MappingType="Name" MappingValue="ADRENAL HYPOPLASIA, CONGENITAL" MappingRef="Preferred">
        <MedGen CUI="C0342482" Name="Congenital adrenal hypoplasia, X-linked" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6133367" TraitType="Disease" MappingType="XRef" MappingValue="C1848296" MappingRef="MedGen">
        <MedGen CUI="C1848296" Name="46,XY sex reversal 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3255188" TraitType="Disease" MappingType="XRef" MappingValue="300200" MappingRef="OMIM">
        <MedGen CUI="C0342482" Name="Congenital adrenal hypoplasia, X-linked" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6133367" TraitType="Disease" MappingType="XRef" MappingValue="C0342482" MappingRef="MedGen">
        <MedGen CUI="C0342482" Name="Congenital adrenal hypoplasia, X-linked" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3255188" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000835" MappingRef="HP">
        <MedGen CUI="C1846223" Name="Adrenal hypoplasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

